Hyper-Dry Amniotic Membrane for Burn Wound Granulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for third-degree burns lack effective methods to prevent infection and promote favorable granulation, leading to poor regeneration and increased risk of complications, including death, due to insufficient wound bed preparation for skin grafting.
Innovation Solution
The use of hyper-dry amniotic membrane (HD-AM) as a covering material and regenerative scaffold, which is produced through a specific drying process, promotes granulation growth by inducing secretion of inflammatory cytokines and growth factors, thereby protecting against infection and enhancing tissue regeneration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If surgical treatment is performed on third-degree burns to remove necrotic tissue, then infection risk is reduced, but wound bed preparation becomes insufficient leading to poor regeneration
Solution Approach 1:
The dried amniotic membrane is applied immediately after debridement to initiate granulation tissue formation before skin grafting. This preliminary action prepares the wound bed in advance, ensuring favorable conditions for subsequent grafting and improving regeneration outcomes.
Solution Approach 2:
The amniotic membrane acts as an intermediary material between the debrided wound bed and the skin graft. It provides a biological scaffold that promotes granulation tissue formation and creates optimal conditions for graft take, bridging the gap between surgical debridement and definitive reconstruction.
2Reliability
If skin grafting is delayed to ensure favorable granulation, then graft engraftment improves, but patient survival time decreases due to prolonged infection risk
Solution Approach 1:
The amniotic membrane is applied immediately after debridement to initiate and accelerate granulation tissue formation. This preliminary action creates favorable wound bed conditions in advance, allowing skin grafting to be performed earlier than conventional protocols while maintaining high engraftment success rates.
Solution Approach 2:
The amniotic membrane changes the temporal parameters of wound healing by accelerating granulation tissue formation. This parameter change allows the wound bed to reach optimal grafting conditions in a shorter time frame, simultaneously improving engraftment success and reducing infection risk period.
3Reliability
If raw amniotic membrane is used as a covering material, then tissue regeneration is promoted, but storage and handling become complicated
Solution Approach 1:
The amniotic membrane is transformed from a fresh, perishable biological tissue into a stable, dried product through controlled dehydration and drying processes. This parameter change in physical state allows the membrane to be stored at room temperature in simple containers and handled without specialized equipment while retaining its regenerative properties.
Solution Approach 2:
The amniotic membrane undergoes a phase transition from a hydrated, perishable state to a dehydrated, stable state. This phase transition enables long-term storage without refrigeration and simplifies handling, while the membrane's biological activity is preserved and can be reactivated upon contact with wound exudate.
4Object-affected harmful factors
If conventional wound dressings are used on third-degree burns, then infection prevention is limited, but granulation promotion is insufficient
Solution Approach 1:
The amniotic membrane represents a composite biological material containing epithelial cells, basement membrane, and connective tissue in a structured arrangement. This composite structure provides both antimicrobial properties for infection prevention and growth factors for granulation promotion, simultaneously addressing both requirements that conventional single-function dressings cannot meet.
Solution Approach 2:
The amniotic membrane serves multiple functions simultaneously: it acts as a physical barrier against infection, provides a scaffold for granulation tissue formation, releases growth factors to promote regeneration, and prepares the wound bed for subsequent grafting. This multi-functionality replaces the need for multiple separate treatments with a single comprehensive material.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
HD-AM actively promotes cell infiltration and secretion of physiologically active substances, leading to effective granulation formation and neovascularization, reducing the risk of infection and improving patient outcomes by facilitating early skin grafting and wound healing.
Implementation Method 1
amniotic membrane produced by rehydrating the dry amniotic membrane by immersion in water or a buffer
Data Source
AI summary
A raw amniotic membrane placed in a processing tank (10) is continuously heated by a far-IR heater (14) provided in the processing tank (10). During a decompression operation in which the interior of the processing tank (10) is placed in a decompressed state, and a recompression operation in which the pressure in the decompressed interior of the processing tank (10) is raised slightly toward atmospheric pressure, the raw amniotic membrane is dried while the water molecules present therein are subjected to energy via microwave irradiation from a microwave irradiation device (30) provided in the processing tank (10). By repeating this multiple times, the amniotic membrane is dried while cells and tissue structures are maintained. The amniotic membrane can be used on a wound site as a coating material or scaffold material after removing a necrosis layer and the like from a severe burn wound patient to retain cytokines and physiologically active substances secreted from infiltrating cells and promote favorable granulation including neoangiogenesis and growth of fibroblasts. This enhances the probability of survival of the patient and therapeutic effect (without the risk of keloid formation).